Central Anatolia · Türkiye
Gastric Balloon in Eskişehir
One of Central Anatolia's leading university and industrial hubs, Eskişehir is home to approximately 0.9 million residents according to TÜİK ADNKS 2024 data. Across Türkiye, obesity is a public health priority, with WHO 2022 modeling placing the country among those with high prevalence in the European Region. The Allurion Program with the swallowable gastric balloon is available at 1 authorized clinic in Eskişehir.
The Allurion Program in Eskişehir — Key Features
No Endoscopy
The procedure is completely non-invasive. The capsule is simply swallowed with water.
15 Minutes
Placement takes 15 minutes and you return home the same day.
Digital Tracking
Six months of expert support with a smart scale and mobile app.
Life in Eskişehir and the City Profile
Located in Central Anatolia, Eskişehir stands out for its university and education identity and is home to a vibrant young population. Well-established higher education institutions such as Anadolu University and Eskişehir Osmangazi University bring the city a large student community from every region of Türkiye. This structure creates a dynamic daily rhythm concentrated in central districts such as Tepebaşı and Odunpazarı.
The city is known for its rail system and urban transit infrastructure; thanks to the high-speed rail (YHT) connection, travel times to Ankara and Istanbul are remarkably short. Bordering Ankara, Bursa, Kütahya, Bilecik, and Afyonkarahisar, Eskişehir occupies a central position for regional mobility.
A young, active population profile, intense student life, eating-out habits, and the irregular meals and sedentary stretches that come with exam or work schedules are among the local factors that keep weight management top of mind for many people. This context makes the interest in non-surgical approaches that cause minimal disruption to daily life easy to understand.
Why Weight Management Matters and the National Picture
Obesity is a health issue that affects a large number of people across Türkiye. According to the TÜİK Türkiye Health Survey 2022, the obesity rate (BMI≥30) among individuals aged 15 and over in Türkiye is 20.2%; the rate was measured at 23.6% in women and 16.8% in men.
Using a different methodology, WHO 2022 modeling places Türkiye among the countries with high obesity prevalence in the European Region at 32.1%. Because these two sources rely on different methods, they should be evaluated separately; the measurement-based TÜİK data and the model-based WHO estimate cannot be used interchangeably.
While no city-specific obesity figure exists for Eskişehir, intense student life, a fast-paced urban rhythm, a tendency toward eating out and irregular meals, and desk- and screen-heavy sedentary periods stand out as qualitative factors that may affect weight balance. Weight management is not merely an aesthetic matter; it is a process that concerns long-term metabolic health, and it is recommended that it be addressed through an individual physician evaluation.
Healthcare Infrastructure and Clinic Access
With its university hospitals and healthcare institutions, Eskişehir has a well-developed healthcare infrastructure for its region. The contemporary standard in obesity management is a multidisciplinary approach in which internal medicine, nutrition and dietetics, and behavioral support disciplines evaluate the patient together; this model, adopted in Ministry of Health-approved obesity centers, treats the process as a holistic program rather than a single procedure.
The Allurion Program with the swallowable gastric balloon is designed to align with this holistic approach. In Eskişehir, the program is offered at 1 authorized clinic; candidates can reach this authorized clinic easily from the city's central districts and via the YHT connection for evaluation and placement.
Allurion operates a network of 60+ authorized centers across Türkiye. This network ensures the program is delivered within a standardized framework under physician supervision; eligibility and follow-up decisions always depend on the evaluation of the treating physician.
How Does the Program Work?
The Allurion Program is a holistic process that combines the swallowable gastric balloon capsule, the smart scale, a mobile app, and a 6-month nutrition and behavior program. The capsule is swallowed with a glass of water during a roughly 15-minute visit at the clinic; it requires no anesthesia, endoscopy, or surgery. After placement, the position is verified by a physician.
The balloon self-empties in the stomach at approximately week 16 and passes naturally from the body; no separate removal procedure is required. Throughout this period, the smart scale and mobile app support adherence to the nutrition and behavior program.
Clinical studies have reported an average of 14.9% total body weight loss (Ienca et al., Obes Surg 2020, N=1,770, PMID 32279182). Results vary from person to person. The device received full FDA approval under PMA Class III on February 23, 2026 (approval no. P250023). Eligibility is generally considered for individuals aged 18 and over with a body mass index (BMI) of 27 or higher; final eligibility is determined by a physician evaluation.
Getting There and Placement Day
Eskişehir's YHT connection is an advantage that simplifies travel for candidates coming from Ankara and Istanbul; access is also possible by road and rail from the neighboring provinces of Ankara, Bursa, Kütahya, Bilecik, and Afyonkarahisar. The city's well-developed urban transit infrastructure makes planning a clinic visit practical.
Because the placement is brief and requires no anesthesia, same-day return is possible in most cases, subject to physician approval and individual evaluation. That said, since the body's adjustment process in the first days after placement can vary from person to person, it is important to follow the clinic's guidance.
Whether you live in Eskişehir or are a candidate traveling from a neighboring province, detailed information about eligibility, the process, and the follow-up plan is shared by the physician during the evaluation visit.
Eskişehir — Frequently Asked Questions
Where is the Allurion Program available in Eskişehir?
In Eskişehir, the program is available at 1 authorized clinic. The clinic is accessible from the city's central districts and, via the YHT connection, from surrounding provinces. Appointments and the evaluation process are handled through the authorized clinic.
Is the Allurion swallowable gastric balloon a non-surgical method?
Yes. The capsule is swallowed with a glass of water during a roughly 15-minute visit at the clinic. It requires no anesthesia, endoscopy, or surgery. After the procedure, the position is verified by a physician.
How is the balloon removed from the body?
The balloon self-empties in the stomach at approximately week 16 and passes naturally from the body. No separate removal procedure or second intervention is required.
Who can benefit from the program?
Eligibility is generally considered for individuals aged 18 and over with a body mass index (BMI) of 27 or higher. Final eligibility is determined by a physician evaluation based on your individual health status.
How much weight loss does it deliver?
Clinical studies have reported an average of 14.9% total body weight loss (Ienca et al., Obes Surg 2020, N=1,770, PMID 32279182). Results vary from person to person. Along with the capsule, the program includes the smart scale, a mobile app, and 6 months of nutrition and behavior support.
How much does the program cost?
Because pricing can vary from clinic to clinic, it would not be accurate to quote a single figure. For current, precise information, it is recommended that you contact the authorized clinic in Eskişehir and schedule an evaluation visit.
Can I travel to Eskişehir from a neighboring province for the placement?
Yes. Access is possible by road and rail from neighboring provinces such as Ankara, Bursa, Kütahya, Bilecik, and Afyonkarahisar, and by YHT from Ankara and Istanbul. Because the placement is brief, same-day return is possible in most cases, subject to physician approval and individual evaluation.
Sources: TÜİK Türkiye Health Survey 2022; TÜİK ADNKS 2024; WHO 2022; Ienca et al., Obes Surg 2020 (PMID 32279182, N=1,770); FDA PMA P250023 (February 23, 2026). Results vary from person to person; this content is not a substitute for medical advice. Record date: June 2026.
Eskişehir: Free Assessment
Fill in the form and a specialist in the Eskişehir area will contact you.
Free Assessment
Let Our Specialists Call You
Let's evaluate together whether it's right for you.
Related Pages
Central Anatolia Region
The Allurion Program
* Weight-loss figures are clinical group averages. Individual results may vary. Source: Ienca et al., Obes Surg 2020; PMID 32279182, N=1,770.